Leptomeningeal Metastases Pipeline Development Research Report 2024, Featuring AstraZeneca, Kazia Therapeutics, and Plus Therapeutics
HGHYX Fund | USD 45.19 2.26 4.76% |
Slightly above 61% of Hartford Healthcare's investor base is looking to short. The analysis of overall sentiment of trading The Hartford Healthcare mutual fund suggests that many investors are alarmed at this time. Hartford Healthcare's investing sentiment can be driven by a variety of factors including economic data, Hartford Healthcare's earnings reports, geopolitical events, and overall market trends.
Hartford |
Dublin, Dec. 05, 2024 -- The Leptomeningeal Metastases - Pipeline Insight, 2024 report has been added to ResearchAndMarkets.coms offering.The latest report on the Leptomeningeal Metastases pipeline, targeting an anticipated release by 2024, serves as a comprehensive resource providing key insights into the advancements in the treatment landscape of this complex and devastating condition. The report encapsulates the vigorous efforts and breakthroughs by leading pharmaceutical
Read at finance.yahoo.com
Hartford Healthcare Fundamental Analysis
We analyze Hartford Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hartford Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hartford Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Hartford Healthcare is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
The Hartford Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hartford Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Hartford Healthcare could also be used in its relative valuation, which is a method of valuing Hartford Healthcare by comparing valuation metrics with similar companies.
Peers
Hartford Healthcare Related Equities
HIAHX | Hartford Healthcare | 0.76 |
| ||
HGHIX | Hartford Global | 1.35 |
| ||
HGHAX | Hartford Healthcare | 1.35 |
| ||
HBGHX | Hartford Healthcare | 1.40 |
| ||
HGHCX | Hartford Healthcare | 7.91 |
|
Other Information on Investing in Hartford Mutual Fund
Hartford Healthcare financial ratios help investors to determine whether Hartford Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hartford with respect to the benefits of owning Hartford Healthcare security.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |